Seoul, Korea
FatiAbGen is a leading antibody engineering company leveraging collaborations across the global biotech ecosystem to deverlop best-in-class therapeuties for high unmet need oncology and immunology conditions. FatiAbGen has a strong global view with passion. FatiAbGen is the first Korean company to be a member of Shonan iPark, the largest biotech cluster in Japan. FatiAbGen became a member of the JLABS family in 2023, strongly aligned with J&J’s innovative portfolio. In 2024, FatiAbGen established a new subsidiary in Basel Switzerland to accelerate business development for future out-licensing.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for FatiAbGen on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.